Akslen LA - Search Results

1

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.

Puntervoll HE, Yang XR, Vetti HH, Bachmann IM, Avril MF, Benfodda M, Catricalà C, Dalle S, Duval-Modeste AB, Ghiorzo P, Grammatico P, Harland M, Hayward NK, Hu HH, Jouary T, Martin-Denavit T, Ozola A, Palmer JM, Pastorino L, Pjanova D, Soufir N, Steine SJ, Stratigos AJ, Thomas L, Tinat J, Tsao H, Veinalde R, Tucker MA, Bressac-de Paillerets B, Newton-Bishop JA, Goldstein AM, Akslen LA, Molven A. Puntervoll HE, et al. Among authors: akslen la. J Med Genet. 2013 Apr;50(4):264-70. doi: 10.1136/jmedgenet-2012-101455. Epub 2013 Feb 5. J Med Genet. 2013. PMID: 23384855 Free PMC article.

2

Metastatic melanoma of unknown origin at autopsy.

Akslen LA, Hartveit F. Akslen LA, et al. Eur J Surg Oncol. 1988 Oct;14(5):379-82. Eur J Surg Oncol. 1988. PMID: 3181440

3

Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma.

Straume O, Akslen LA. Straume O, et al. Among authors: akslen la. Int J Cancer. 1997 Oct 21;74(5):535-9. doi: 10.1002/(sici)1097-0215(19971021)74:5<535::aid-ijc10>3.0.co;2-5. Int J Cancer. 1997. PMID: 9355977

4

Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma.

Halvorsen OJ, Høstmark J, Haukaas S, Høisaeter PA, Akslen LA. Halvorsen OJ, et al. Among authors: akslen la. Cancer. 2000 Jan 15;88(2):416-24. Cancer. 2000. PMID: 10640976

5

Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma.

Straume O, Sviland L, Akslen LA. Straume O, et al. Among authors: akslen la. Clin Cancer Res. 2000 May;6(5):1845-53. Clin Cancer Res. 2000. PMID: 10815907

6

Frequent loss of p16 protein expression and high proliferative activity (Ki-67) in malignant melanoma from black Africans.

Vuhahula E, Straume O, Akslen LA. Vuhahula E, et al. Among authors: akslen la. Anticancer Res. 2000 Nov-Dec;20(6C):4857-62. Anticancer Res. 2000. PMID: 11205232

7

Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase.

Straume O, Smeds J, Kumar R, Hemminki K, Akslen LA. Straume O, et al. Among authors: akslen la. Am J Pathol. 2002 Jul;161(1):229-37. doi: 10.1016/S0002-9440(10)64174-0. Am J Pathol. 2002. PMID: 12107107 Free PMC article.

8

Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas.

Bachmann IM, Straume O, Akslen LA. Bachmann IM, et al. Among authors: akslen la. Int J Oncol. 2004 Dec;25(6):1559-65. Int J Oncol. 2004. PMID: 15547691

9

BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival.

Akslen LA, Angelini S, Straume O, Bachmann IM, Molven A, Hemminki K, Kumar R. Akslen LA, et al. J Invest Dermatol. 2005 Aug;125(2):312-7. doi: 10.1111/j.0022-202X.2005.23788.x. J Invest Dermatol. 2005. PMID: 16098042 Free article.

10

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.

Bachmann IM, Halvorsen OJ, Collett K, Stefansson IM, Straume O, Haukaas SA, Salvesen HB, Otte AP, Akslen LA. Bachmann IM, et al. Among authors: akslen la. J Clin Oncol. 2006 Jan 10;24(2):268-73. doi: 10.1200/JCO.2005.01.5180. Epub 2005 Dec 5. J Clin Oncol. 2006. PMID: 16330673

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters